Laurent Fischer
Net Worth
Last updated:
What is Laurent Fischer net worth?
The estimated net worth of Dr. Laurent Fischer is at least $6,656,487 as of 15 Mar 2023. He owns shares worth $1,965,680 as insider, has earned $76,207 from insider trading and has received compensation worth at least $4,614,600 in Adverum Biotechnologies, Inc..
What is the salary of Laurent Fischer?
Dr. Laurent Fischer salary is $922,920 per year as Pres, Chief Executive Officer, Interim CMO & Director in Adverum Biotechnologies, Inc..
How old is Laurent Fischer?
Dr. Laurent Fischer is 61 years old, born in 1964.
What stocks does Laurent Fischer currently own?
As insider, Dr. Laurent Fischer owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Adverum Biotechnologies, Inc. (ADVM) | Pres, Chief Executive Officer, Interim CMO & Director | 692,141 | $2.84 | $1,965,680 |
What does Adverum Biotechnologies, Inc. do?
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.
Laurent Fischer insider trading
Adverum Biotechnologies, Inc.
Dr. Laurent Fischer has made 2 insider trades between 2020-2023, according to the Form 4 filled with the SEC. Most recently he sold 41,239 units of ADVM stock worth $32,249 on 15 Mar 2023.
The largest trade he's ever made was exercising 41,239 units of ADVM stock on 15 Mar 2023. As of 15 Mar 2023 he still owns at least 692,141 units of ADVM stock.
Adverum Biotechnologies key executives
Adverum Biotechnologies, Inc. executives and other stock owners filed with the SEC:
- Dr. Laurent Fischer (61) Pres, Chief Executive Officer, Interim CMO & Director